Unisom

By Z. Orknarok. Yale University. 2019.

Smoking is a preferred route of crack cocaine administration due to rapid onset generic 25mg unisom fast delivery, intensity and euphoria purchase unisom 25mg, even though pipes and smoking apparatus become hot and may burn the lips unisom 25 mg amex. In general buy unisom 25mg online, the efficiency and speed of drug delivery (the faster it is deliv- ered to the brain) increases the potential for abuse and dependency. This process is largely determined by the physical and chemical properties of the drug. Most drugs can be characterized as acidic, basic or neutral, and unlike alcohol, which is highly water-soluble, many drugs are also soluble in fat or lipids. The degree to which a particular drug is water-soluble or fat-soluble influences how it is distributed throughout the body. Distribution As soon as the drug is absorbed into the bloodstream, it is circulated to surrounding tissues and organs, and the distribution phase begins. Drugs that are lipid (fat) soluble are distributed more readily into the tissues, such as the heart, liver, kidney, brain and fat. The extent to which a drug is distributed in the body is given by its volume of distribution (Vd). Conversely, drugs with large volumes of distribution, like heroin (Vd = 25 L/kg), are widely distributed throughout the body, including the tissues (Table 5). Alternatively, some drug metabolites may be pharmacologically active, therefore contributing to the overall effect, such as: • Metabolism of diazepam to nordiazepam (an active metabolite of many benzodiazepines) • Carisoprodol to meprobamate • Codeine to morphine There are a great many variables that can affect drug metabolism, includ- ing age, sex, genetic polymorphisms (common genetic mutations that may relate to specific genetic predispositions), health, disease and nutrition. Elimination Elimination is the pharmacokinetic process of getting the drug out of the body. Drugs are eliminated in two major ways—referred to as zero order and first order kinetics or elimination. Ethanol is eliminated at a fixed or linear rate which means that the body eliminates it at a relatively constant amount per unit of time (zero order kinetics). However, most drugs are eliminated using first order kinetics, which means that elimination is non- linear. When a drug is metabolized in a non-linear fashion, it is generally not possible to extrapolate backwards from some known drug concentration to some earlier time and concen- tration. Figure 1 illustrates both zero and first order kinetics on a graph that plots drug concentration over time. The zero order line is straight, while the first order line curves over time, depending upon a drug’s specific half-life. It is important to understand the overall dynamic nature of drug phar- macokinetics. The processes of absorption, distribution, metabolism and elimi- nation do not occur in a discrete chronological fashion, one simply fol- lowing completion of the other, but rather, they occur in combination with each other. Initially following drug administration, absorption will likely prevail; later, absorption wanes and elimination becomes the dominant process in the body. Corresponding drug and metabolite concentrations therefore represent the overall net effect of the pharmacokinetic processes at the time of sampling. Similarly, corresponding drug effects are also related to drug pharmacokinetics, or the timeline of drug use. For exam- ple, initial effects of methamphetamine may include intense euphoria, talkativeness and excitement, followed by dysphoria (unpleasant feelings), lethargy and anxiety several hours later. In addition to the relatively complex way in which many drugs are eliminated, the additional pres- ence of active metabolites creates yet another level of consideration or complexity to the interpretation. A simpler way to consider elimination is this analogy: a baseball dropped by a 10-year-old child sitting in a tree house, high above the ground, will fall straight down (alcohol zero order elimination). If that same 10-year-old then drops a maple leaf attached to an acorn, it should hit the ground at about the same time as the baseball (other drugs with zero order elimination). It will drop much more slowly—as it is tossed and turned in the breeze—than the baseball or the leaf and acorn. The leaf’s size also changes during its descent as pieces break off in the wind (changing drug half-life); this also causes its rate of descent to slow. Eventually the leaf gets to the ground, but not in a straight line nor in a necessarily highly predictable time frame (drug first order elimination). The effect of a drug is a result of the drug’s interaction at a given receptor site. Drugs that affect the central nervous system must reach and bind to specific receptors for their effects to be exhibited. These drugs act to either stimulate or depress certain areas of the brain to achieve a response, i. Typically, an increase in the concentration of the drug modulates the receptor response and enhances the pharmacologic effect. A relationship exists between the amount of drug administered (dose) and the corresponding effect (response) on the body, including the extent to which it may “impair” normal function. Residual effects may exist long after the “acute” effects of the drug have been experienced (Table 5). The link between the amount of drug and its effect over time is the basis for establishing therapeutic and toxic drug concentrations. These ranges are widely published for clinical purpos- es, but there are no “therapeutic concentrations” for many illicit drugs. Remember: A habitual drug user may develop a tolerance to the toxic effects of a drug, allowing him or her to withstand concentra- tions of drug that may be highly toxic or even fatal in a naïve (inexpe- rienced) subject. For example, after consuming ethanol, a person tends to feel more excited and euphoric during the initial absorp- tion phase than during the elimination phase, during which time they may feel more sedated and depressed (Mellanby effect). However, several hours later, the same drug concentration may coincide with confusion, depression, anxiety and exhaustion during the elimination phase. For the purpose of determining impairment, acute or chronic toxicity, blood is considered by most to be the preferred specimen. While a number of laboratories across the country use urine samples with great success, the presence of the drug in urine is an indication of drug exposure over a period of hours, days or even weeks (evidence of past use). For this reason, additional information such as obser- vations, behavior or clinical signs is very important to the toxicologist. With the exception of ethanol, there is so far no widely accepted correla- tion between the drug concentration in blood and a corresponding level of driving impairment among the scientific community. What is more, factors such as tolerance can have a profound effect on the pharmacodynamic response in an individual. A quantity of cocaine sufficient to produce a mild “buzz” in a chronic user could be acutely cardiotoxic in a naïve (inexperienced) user, resulting in coma and death. Remember: Vital signs, symptoms and behavioral response observed by clinicians and law enforcement personnel are highly relevant during toxicological interpretation. D rugs can impair driving by affecting some of the important skills necessary for safe operation of a vehicle (Table 6). In fact, drug manufac- turers commonly issue warnings for prescription or over-the-counter drugs, indicating that the drug may impair mental or physical abilities required for performing hazardous tasks such as driving. Coordination Coordination and psychomotor control are essential because driving is a physical task. Drugs that affect nerves and muscles may impair braking, steering, acceleration and manipulation of the vehicle. Braking too suddenly or too late, or using the wrong amount of force on the steering wheel and over- or under-correcting, can result from drug impairment. Judgment / Decision-making Drivers must process information and then make appropriate decisions. Some drugs affect cognition and have the potential to impair the ability to concentrate, detect, anticipate risk, avoid hazards or make emergency decisions. For example, stimulants like cocaine or methamphetamine can produce exhilaration, excitement and feelings of mental and physical power. Drugs that can produce visual or auditory distortions, or drugs that can affect per- ception of time and distance (e. Visual disturbances are also reported with other drugs, such as cocaine, which can cause flashes of light in peripher- al vision, known as “snow lights. This is sometimes observed as weaving or the inability to maintain the vehicle within the lane (the constant minor over-correc- tions seen in an attempt to stay within the lane). Reaction Time A driver must not only receive information, but must also process it, make a decision, and then react. Slowed reaction times (reaction deficits), particularly with respect to braking and steering, may result in character- istic driving behavior, for example, striking a fixed object, rear-ending another vehicle, or failure to make an evasive maneuver. Divided Attention and Multitasking Driving requires divided attention, rather than focused attention.

Usage: For single‐unit recordings is the only appropriate barbiturate since pentobarbital suppresses cell activity purchase 25mg unisom with amex. Intravenous Non­barbiturate Anesthetics Diprivan Injection (Propofol) Description: Diprivan Injection is an intravenous sedative hypnotic agent for use in the induction and maintenance of anesthesia or sedation cheap 25mg unisom otc. Intravenous injection of a therapeutic dose of propofol produces hypnosis rapidly with minimal excitation buy unisom 25mg line, usually within 40 seconds from the start of an injection (the time for one arm‐ brain circulation) discount unisom 25mg free shipping. As with other rapidly acting intravenous anesthetic agents, the half‐time of the blood‐brain equilibration is approximately 1 to 3 minutes, and this accounts for the rapid induction of anesthesia. The pharmacodynamic properties of propofol are dependent upon the therapeutic blood propofol concentrations. Steady state propofol blood concentrations are generally proportional to infusion rates, especially within an individual patient. Undesirable side effects such as cardiorespiratory depression are likely to occur at higher blood concentrations which result from bolus dosing or rapid increase in infusion rate. An adequate interval (3 to 5 minutes) must be allowed between clinical dosage adjustments in order to assess drug effects. The hemodynamic effects of Diprivan Injection during induction of anesthesia vary. If spontaneous ventilation is maintained, the major cardiovascular effects are arterial hypotension (sometimes greater than a 30% decrease) with little or no change in heart rate and no appreciable decrease in cardiac output. If ventilation is assisted or controlled (positive pressure ventilation), the degree and incidence of decrease in cardiac output are accentuated. If anesthesia is continued by infusion of Diprivan Injection, the stimulation of endotracheal intubation and surgery may return arterial pressure towards normal. During maintenance, Diprivan Injection causes a decrease in ventilation usually associated with an increase in carbon dioxide tension which may be marked depending upon the rate of administration and other concurrent medications (e. As with other sedative hypnotic agents, the amount of intravenous opioid and/or benzodiazepine premedication will influence the response of the patient to an induction dose of Diprivan Injection. Attention should be paid to minimize pain on injection when administering Diprivan Injection to animals. Rapid boluses of Diprivan Injection may be administered if small veins are pretreated with lidocaine or when antecubital or larger veins are utilized. Maintenance Of General Anesthesia: Maintenance by infusion of Diprivan Injection at a rate of 200‐300 mcgm/kg/min should immediately follow the induction dose. Following the first half hour of maintenance, if clinical signs of light anesthesia are not present, the infusion rate should be decreased; during this period, infusion rates of 125‐150 mcgm/kg/min are typically needed. However, younger children (5 years or less) may require larger maintenance infusion rates than older children. Precautions: Monkeys should be continuously monitored for early signs of significant hypotension and/or bradycardia. Treatment may include increasing the rate of intravenous fluid, elevation of lower extremities, use of pressor agents, or administration of atropine. Attention should be paid to minimize pain on administration of Diprivan Injection. Transient local pain can be minimized if the larger veins of the forearm or leg (e. With lidocaine pretreatment, pain is minimal (incidence less than 10%) and well tolerated. In two well‐ controlled clinical studies using dedicated intravenous catheters, no instances of venous sequelae were observed up to 14 days following induction. Accidental intra‐ arterial injection has been reported in human patients, and, other than pain, there were no major sequelae. Intentional injection into subcutaneous or perivascular tissues of animals caused minimal tissue reaction. During the post‐marketing period, there have been rare reports of local pain, swelling, blisters, and/or tissue necrosis following accidental extravasation of Diprivan Injection. Perioperative myoclonia, rarely including convulsions and opisthotonos, has occurred in temporal relationship in cases in which Diprivan Injection has been administered. Clinical features of anaphylaxis, which may include angioedema, bronchospasm, erythema and hypotension, occur rarely following Diprivan Injection administration, although use of other drugs in most instances makes the relationship to Diprivan Injection unclear. There have been rare reports of pulmonary edema in temporal relationship to the administration of Diprivan Injection, although a causal relationship is unknown. Reports of bradycardia, asystole, and rarely, cardiac arrest have been associated with Diprivan Injection. Drug Interactions: The induction dose requirements of Diprivan Injection may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (e. These agents may increase the anesthetic or sedative effects of Diprivan Injection and may also result in more pronounced decreases in systolic, diastolic, and mean arterial pressures and cardiac output. Diprivan Injection does not cause a clinically significant change in onset, intensity or duration of action of the commonly used neuromuscular blocking agents (e. No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of muscle relaxants, inhalational agents, analgesic agents, and local anesthetic agents) have been observed. If overdosage occurs, Diprivan Injection administration should be discontinued immediately. A minimum period of 5 minutes between adjustments should be allowed for onset of peak drug effect. In diluted form it has been shown to be more stable when in contact with glass than with plastic (95% potency after 2 hours of running infusion in plastic). Administration With Other Fluids: Compatibility of Diprivan Injection with the coadministration of blood/serum/plasma has not been established. Diprivan Injection has been shown to be compatible when administered with the following intravenous fluids. Propofol undergoes oxidative degradation, in the presence of oxygen, and is therefore packaged under nitrogen to eliminate this degradation path. Diprivan Injection is a sterile emulsion containing 10 mg/mL of propofol suitable for intravenous administration. In addition to the active component, propofol, the formulation also contains soybean oil (100 mg/mL), glycerol (22. Xylazine Description: Xylazine is a non‐narcotic compound acting as sedative and analgesic as well as a muscle relaxant. Usage: We mainly use it in combination with Ketamine for minor procedures, which however require the avoidance of unwanted animal‐movements. The combination of ketamine and xylazine provides effect anesthesia for moderate duration procedures. Conduction block can be demonstrated in squid giant axons from which the axoplasm has been removed. Local anesthetics block conduction by decreasing or preventing the large transient increase in the permeability of excitable membranes to Na+ that normally is produced by a slight depolarization of the membrane. This action of local anesthetics is due to their direct interaction with voltage‐gated Na+ channels. As the anesthetic action progressively develops in a nerve, the threshold for electrical excitability gradually increases, the rate of rise of the action potential declines, impulse conduction slows, and the safety factor for conduction decreases; these factors decrease the probability of propagation of the action potential, and nerve conduction fails. In addition to Na+ channels, local anesthetics also can bind to other membrane proteins. However, since the interaction of local anesthetics with K+ channels requires higher concentrations of drug, blockade of conduction is not accompanied by any large or consistent change in resting membrane potential due to block of K+ channels. Quaternary analogs of local anesthetics block conduction when applied internally to perfused giant axons of squid, but they are relatively ineffective when applied externally. These observations suggest that the site at which local anesthetics act, at least in their charged form, is accessible only from the inner surface of the membrane. Therefore, local anesthetics applied externally first must cross the membrane before they can exert a blocking action. Although a variety of physicochemical models have been proposed to explain how local anesthetics achieve conduction block, it is now generally accepted that the major mechanism of action of these drugs involves their interaction with one or more specific binding sites within the Na+ channel. Lidocaine Lidocaine is used to produce local anesthesia following subcutaneous injection. It is readily absorbed following parenteral administration and thus does not long remain at the site of injection. Muscle Relaxants Vecuronium bromide Description: Norcuron (vecuronium bromide) for injection is a nondepolarizing neuromuscular blocking agent of intermediate duration. Norcuron is supplied as a sterile nonpyrogenic freeze‐dried buffered cake of very fine microscopic crystalline particles for intravenous injection only.

For 96 Moles and millimoles example order unisom australia, one hundred 1p coins weigh 356 g trusted 25 mg unisom; it is quicker to weigh 356g of 1p coins than to count a hundred coins buy unisom. Now consider a single molecule of sodium chloride (NaCl) which consists of one sodium ion (Na+) and one chloride ion (Cl–) proven 25 mg unisom. NaCl = molecule Na+ Cl– = ions Since moles can refer to ions as well as molecules, it can be seen that one mole of sodium chloride contains one mole of sodium ions and one mole of chloride ions. From tables (see the end of this section), the relative ionic masses are: sodium (Na) 23 chloride (Cl) 35. The ‘2’ after the ‘Cl’ means two ions of chlorine: CaCl2 = molecule Ca2+ Cl– +Cl– = ions The molecular mass of calcium chloride is 147. The reason why the molecular mass does not always equal the sum of the atomic masses of the individual ions is because water forms a part of each calcium chloride molecule. From the molecular formula and knowledge of the atomic weights it can be seen that calcium chloride contains: 1moleofCa=40g 2 moles of Cl = 71g 2 moles of H2O, each mole of water = 18g; 2 × 18 = 36g What are moles and millimoles 97 So adding everything together: (40 + 71 +36) = 147 i. One millimole is equal to one- thousandth of a mole One micromole is equal to one- thousandth of a millimole It follows that: 1 mole contains1,000 millimoles (mmol) 1 millimole contains1,000 micromoles (mcmol) So, in the above explanation, you can substitute millimoles for moles and 98 Moles and millimoles milligrams for grams. For our purposes: Sodium chloride would give sodium + chloride 1 mole or 1 mole or 1 mole or 1 millimole 1 millimole 1 millimole 58. It is unlikely that you will encounter these types of calculations on the ward, but it is useful to know how they are done and they can be used for reference if necessary. So it follows that the amount (in milligrams) equal to 1 millimole of sodium chloride will give 1 millimole of sodium. In this case, calculate the total amount (in milligrams) of sodium chloride and convert this to millimoles to find out the number of millimoles of sodium. Calculations involving moles and millimoles 99 So 1 millimole of sodium chloride (NaCl) will weigh 58. First work out the number of millimoles for 1 mg of sodium chloride, and then the number for the total amount. Alternatively, a formula can be used: mg/mL total number of millimoles = × volume(mL) mg of substtance containing 1mmol where, in this case mg/mL = 1. Conversion of percentage strength (% w/v) to millimoles Sometimes it may be necessary to convert percentage strength to the number of millimoles. All you need to do is to convert the percentage strength to the number of milligrams in the required volume, then follow the steps as before. So, the amount (in milligrams) equal to 1 millimole of sodium chloride will give 1 millimole of sodium. A formula can be devised: percentage strength (% w/v) mmol = × 10 × volume (mL) mg of substance ccontaining 1mmol In this example: percentage strength (% w/v) = 0. When moles of substances are dissolved in water to make solutions, the unit of concentration is molarity and the solutions are known as molar solutions. When one mole of a substance is dissolved in one litre of solution, it is known as a one molar (1M) solution. If 2 moles of a substance are made up to 1 litre (or 1 mole to 500mL), the solution is said to be a two molar (2M) solution. To do this, you need to calculate the equivalent number of moles per litre (1,000mL). Alternatively, a formula can be derived: number of moles concentration (mol/L or M) = volume in litres The number of moles is calculated from the weight (in g) and the molecular mass: weight (g) moles = molecular mass Molar solutions and molarity 103 To convert the volume (in mL) to litres, divide by 1,000: volume in litres = Putting these together gives the following formula: number of moles concentration (mol/L or M)= = volume in litres Re-writing this gives: concentration (mol/L or M)= In this example: weight (g) = 18 molecular mass = 294 volume (mL) = 200 Substitute the figures into the formula: concentration = = 0. Alternatively, a formula can be derived: number of moles concentration (mol/L or M) = volume in litres so: number of moles = concentration (mol/L or M) × volume in litres We want to go a step further and calculate a weight (in grams) instead of number of moles. The number of moles is calculated from the weight (in grams) and the molecular mass: weight (g) moles = molecular mass To convert the volume (in mL) to litres, divide by 1,000: volume in litres = Putting these together gives the following formula: weight (g) moles = = concentration (mol/L or M)× molecular mass Re-writing this gives: concentration (mol/L or M) × molecular mass ×× final volume (mL) weight (g) = 1,000 Molar solutions and molarity 105 In this example: concentration (mol/L or M) = 0. Conversion of Dosages to mL/hour • In this type of calculation, it is best to convert the dose required to a volume in millilitres. Conversion of mL/hour Back to a Dose • Sometimes it may be necessary to convert mL/hour back to the dose in mg/min or mcg/min and mg/kg/min or mcg/kg/min. Drip rate calculations (drops/min) 107 • If doses are expressed in terms of milligrams, then there is no need to multiply by 1,000. The first (drops/min) is mainly encountered when infusions are given under gravity as with fluid replacement. The second (mL/hour) is encountered when infusions have to be given accurately or in small volumes using infusion or syringe pumps – particularly if drugs have to be given as infusions. The drip rate of the giving set is always written on the wrapper if you are not sure. To do this, multiply the volume of the infusion by the number of ‘drops per mL’ for the giving set, i. If the infusion is being given over a period of minutes, then obviously there is no need to convert from hours to minutes. The final answer needs to be in terms of hours, so multiply by 60 to convert minutes into hours: 136 × 60 = 8,160mcg/hour Convert mcg to mg by dividing by 1,000: = 8. Conversion of dosages to mL/hour 111 A formula can be derived: mL/hour = In this case: total volume to be infused = 500mL total amount of drug (mg) = 800mg dose = 2mcg/kg/min patient’s weight = 68kg 60 converts minutes to hours 1,000 converts mcg to mg Substituting the numbers into the formula: = 5. If the dose is given as a total dose and not on a weight basis, then the patient’s weight is not needed. Conversion of dosages to mL/hour 113 How to use the table If you need to give a 250 mL infusion over 8 hours, then to find the infusion rate (mL/hour) go down the left-hand (Vol) column until you reach 250 mL; then go along the top (Time) line until you reach 8 (for 8 hours). Aminophylline injection comes as 250mg in 10mL ampoules and should be given in a 500mL infusion bag. Question 8 You need to give aciclovir (acyclovir) as an infusion at a dose of 5 mg/kg every 8 hours. Each vial needs to be reconstituted with 20mL Water for Injection and diluted further to 100mL. After reconstitution a 500 mg vial of vancomycin should be diluted with infusion fluid to 5mg/mL. Question 12 You are asked to give an infusion of dobutamine to a patient weighing 73kg at a dose of 5mcg/kg/min. Question 13 You are asked to give an infusion of isosorbide dinitrate 50mg in 500mL of glucose 5% at a rate of 2mg/hour. For example, you may need to check that an infusion pump is giving the correct dose. Nurses changing shifts, especially on the critical care wards, must check that the pumps are set correctly at the beginning of each shift. Now check your answer against the dose written on the drug chart to see if the pump is delivering the correct dose. If your answer does not match the dose written on the drug chart, then re-check your calculation. If the answer is still the same, then inform the doctor and, if necessary, calculate the correct rate. If the dose is given as a total dose and not on a weight basis, then the patient’s weight is not needed: mcg/min = Note: If the dose is in terms of milligrams, then there is no need to multiply by 1,000 (i. Question 15 You have dobutamine 250 mg in 50 mL and the rate at which the pump is running is 5. Question 16 You have dopexamine 50 mg in 50 mL and the rate at which the pump is running is 28 mL/hour. Also, it is a good way of checking your calculated drip rate or pump rate for an infusion. You have calculated that the drip rate should be 42 drops/min (using a standard giving set: 20 drops/mL) or 125mL/hour for a pump. To check your answer, you can calculate how long the infusion should take at the calculated rate. If your answers do not correspond (the answer should be 8 hours), then you have made an error and should re-check your calculation. Alternatively, you can use this type of calculation to check the rate of an infusion already running. For example: if an infusion is supposed to run over 6 hours, and the infusion is nearly finished after 4 hours, you can check the rate by calculating how long the infusion should take using that drip rate or the rate set on the pump. If the calculated answer is less than 6 hours, then the original rate was wrong and the doctor should be informed. A formula can be used: number of hours the infusion is to run = × drip rate of giving set where in this case: volume of the infusion = 1,000mL rate (drops/min) = 42 drops/min drip rate of giving set = 20 drops/mL 60 converts minutes to hours Substituting the numbers into the formula: × 20 = 7. Phamacokinetics and Pharmacodynamics Pharmacokinetics examines the way in which the body ‘handles drugs’ and looks at: • absorption of drugs into the body; • distribution around the body; • elimination or excretion. Pharmacodynamics is the study of the mode of action of drugs – how they exert their effect.

Levofloxacin and ofloxacin are effective the partner during the 60 days preceding the patient’s onset treatment alternatives proven 25 mg unisom, but they are more expensive and offer of symptoms or chlamydia diagnosis 25 mg unisom with visa. Other quinolones either intervals defined for the identification of at-risk sex partners are are not reliably effective against chlamydial infection or have based on limited data buy unisom in india, the most recent sex partner should be not been evaluated adequately buy cheap unisom. Other Management Considerations Among heterosexual patients, if health department partner To maximize adherence with recommended therapies, management strategies (e. To minimize disease transmission to sex partners, Compared with standard patient referral of partners, this persons treated for chlamydia should be instructed to abstain approach to therapy, which involves delivering the medication from sexual intercourse for 7 days after single-dose therapy itself or a prescription, has been associated with decreased or until completion of a 7-day regimen and resolution of rates of persistent or recurrent chlamydia (93–95). To minimize risk for reinfection, patients should also provide patients with written educational materials also should be instructed to abstain from sexual intercourse to give to their partner(s) about chlamydia in general, to until all of their sex partners are treated. Having partners accompany patients recommended because the continued presence of nonviable when they return for treatment is another strategy that has been organisms (394,395,519) can lead to false-positive results. Erythromycin estolate is contraindicated during pregnancy because of drug-related hepatotoxicity. Thus, alternative drugs should be Chlamydial Infections Among Neonates used to treat chlamydia in pregnancy. Clinical experience and Prenatal screening and treatment of pregnant women is published studies suggest that azithromycin is safe and effective the best method for preventing chlamydial infection among (523–525). Although is recommended because severe sequelae can occur in mothers the efficacy of neonatal ocular prophylaxis with erythromycin and neonates if the infection persists. In addition, all pregnant ophthalmic ointments to prevent chlamydia ophthalmia women who have chlamydial infection diagnosed should be is not clear, ocular prophylaxis with these agents prevents retested 3 months after treatment. Women aged <25 years and rectum, although infection might be asymptomatic in these those at increased risk for chlamydia (e. Specimens for chlamydial testing should be collected from Treatment of Ophthalmia Neonatorum the nasopharynx. Tissue culture is the definitive standard diagnostic test for chlamydial pneumonia. Infants treated with either of these antimicrobials should be should be tested for C. Treatment Because test results for chlamydia often are not available Although data on the use of azithromycin for the treatment at the time that initial treatment decisions must be made, of neonatal chlamydia infection are limited, available data treatment for C. The results of tests for chlamydial infection assist Follow-Up in the management of an infant’s illness. Because the efficacy of erythromycin treatment for Recommended Regimen ophthalmia neonatorum is approximately 80%, a second Erythromycin base or ethylsuccinate 50 mg/kg/day orally divided into course of therapy might be required (531). Data on the efficacy 4 doses daily for 14 days of azithromycin for ophthalmia neonatorum are limited. Therefore, follow-up of infants is recommended to determine whether initial treatment was effective. The possibility of Alternative Regimen concomitant chlamydial pneumonia should be considered (see Azithromycin 20 mg/kg/day orally, 1 dose daily for 3 days Infant Pneumonia Caused by C. Management of Mothers and Their Sex Partners Mothers of infants who have ophthalmia caused by chlamydia Follow-Up and the sex partners of these women should be evaluated and Because the effectiveness of erythromycin in treating presumptively treated for chlamydia. Data on the effectiveness of azithromycin in treating chlamydial Infant Pneumonia Caused by C. Follow-up of infants is recommended Chlamydia pneumonia in infants typically occurs at to determine whether the pneumonia has resolved, although 1–3 months and is a subacute pneumonia. Characteristic some infants with chlamydial pneumonia continue to have signs of chlamydial pneumonia in infants include 1) a abnormal pulmonary function tests later in childhood. In addition, peripheral eosinophilia (≥400 cells/mm3) occurs Mothers of infants who have chlamydia pneumonia and the frequently. For more information, Other Management Considerations see Chlamydial Infection in Adolescents and Adults. Neonates Born to Mothers Who Have Follow-Up Chlamydial Infection A test-of-cure culture (repeat testing after completion Neonates born to mothers who have untreated chlamydia of therapy) to detect therapeutic failure ensures treatment are at high risk for infection; however, prophylactic antibiotic effectiveness. Therefore, a culture should be obtained at treatment is not indicated, as the efficacy of such treatment is a follow-up visit approximately 2 weeks after treatment unknown. Chlamydial Infections Among Infants Gonococcal Infections and Children Gonococcal Infections in Adolescents Sexual abuse must be considered a cause of chlamydial and Adults infection in infants and children. Clinicians should consider the communities they serve and might opt to consult local public health authorities for guidance on identifying groups at increased risk. Gonococcal Recommended Regimen for Children Who Weigh ≥45 kg but infection, in particular, is concentrated in specific geographic Who Are Aged <8 Years locations and communities. Screening for gonorrhea in men and older women who are at low risk for infection is not recommended Recommended Regimens for Children Aged ≥8 years (108). A recent travel history with sexual contacts outside of Azithromycin 1 g orally in a single dose the United States should be part of any gonorrhea evaluation. However, during have comparable low specificity when testing oropharyngeal 2006–2011, the minimum concentrations of cefixime specimens for N. In addition, treatment failures with cefixime failure, clinicians should perform both culture and antimicrobial or other oral cephalosporins have been reported in Asia (541– susceptibility testing because nonculture tests cannot provide 544), Europe (545–549), South Africa (550), and Canada antimicrobial susceptibility results. Ceftriaxone treatment failures for pharyngeal demanding nutritional and environmental growth requirements, infections have been reported in Australia (553,554), Japan optimal recovery rates are achieved when specimens are (555), and Europe (556,557). Consequently, only one Because of its high specificity (>99%) and sensitivity regimen, dual treatment with ceftriaxone and azithromycin, (>95%), a Gram stain of urethral secretions that demonstrates is recommended for treatment of gonorrhea in the United polymorphonuclear leukocytes with intracellular Gram- States. Extensive clinical experience indicates of relevant clinical specimens, consult an infectious-disease that ceftriaxone is safe and effective for the treatment of specialist for guidance in clinical management, and report the uncomplicated gonorrhea at all anatomic sites, curing 99. None of these injectable cephalosporins offer any advantage Dual Therapy for Gonococcal Infections over ceftriaxone for urogenital infection, and efficacy for On the basis of experience with other microbes that have pharyngeal infection is less certain (566,567). Several other developed antimicrobial resistance rapidly, a theoretical basis antimicrobials are active against N. Few antimicrobial regimens, including (118), the use of azithromycin as the second antimicrobial those involving oral cephalosporins, can reliably cure >90% is preferred. However, in the case of azithromycin allergy, of gonococcal pharyngeal infections (566,567). This trial was not powered to provide reliable estimates of the efficacy of these Other Management Considerations regimens for treatment of rectal or pharyngeal infection, To maximize adherence with recommended therapies but both regimens cured the few extragenital infections and reduce complications and transmission, medication among study participants. Either of these regimens might be for gonococcal infection should be provided on site and considered as alternative treatment options in the presence directly observed. When available, spectinomycin is an effective alternative diagnosis of uncomplicated urogenital or rectal gonorrhea for the treatment of urogenital and anorectal infection. Persistent urethritis, cervicitis, Allergy, Intolerance, and Adverse Reactions or proctitis also might be caused by other organisms (see Allergic reactions to first-generation cephalosporins occur Urethritis, Cervicitis, and Proctitis sections). Rather than signaling treatment or cefixime is contraindicated in persons with a history of failure, most of these infections result from reinfection caused an IgE-mediated penicillin allergy (e. Potential therapeutic options be retested 3 months after treatment regardless of whether they are dual treatment with single doses of oral gemifloxacin believe their sex partners were treated. If retesting at 3 months 320 mg plus oral azithromycin 2 g or dual treatment with is not possible, clinicians should retest whenever persons single doses of intramuscular gentamicin 240 mg plus oral next present for medical care within 12 months following azithromycin 2 g (569). Providers treating persons with cephalosporin or IgE-mediated penicillin allergy should consult an infectious- Recent sex partners (i. When cephalosporin allergy or other considerations instructed to abstain from unprotected sexual intercourse for preclude treatment with this regimen and spectinomycin is 7 days after they and their sexual partner(s) have completed not available, consultation with an infectious-disease specialist treatment and after resolution of symptoms, if present. For more information, see appropriate treatment be delivered to the partner by the patient, a disease investigation sections under Gonoccocal Infections. With this approach, provision of Suspected Cephalosporin Treatment Failure medication must be accompanied by written materials (93,95) Cephalosporin treatment failure is the persistence of to educate partners about their exposure to gonorrhea, the N. Educational materials resistant gonorrhea in persons whose partners were adequately for female partners should include information about the treated and whose risk for reinfection is low. Persons with report no sexual contact during the post-treatment follow-up suspected treatment failure after treatment with the alternative period and 2) persons with a positive test-of-cure (i. A test-of-cure at relevant clinical sites during the post-treatment follow-up period (579). Because gonococcal conjunctivitis is susceptibility testing by agar dilution; local laboratories should uncommon and data on treatment of gonococcal conjunctivitis store isolates for possible further testing if needed. Testing in adults are limited, consultation with an infectious-disease and/or storage of specimens or isolates should be facilitated by specialist should be considered. For more information, see Suspected treatment failures first should be retreated Gonococcal Infections, Management of Sex Partners. The infection is complicated occasionally by susceptibility testing performed before retreatment.